Slow progressive acceptance of intravenous thrombolysis for patients with stroke by rural primary care physicians

Archives of Neurology

Volumn 64, Issue 4, 2007, Pages 518-521

  Leira, Enrique C ^a,b   Pary, Jennifer K ^b   Davis, Patricia H ^b   Grimsman, Karla J ^b   Adams Jr , Harold P ^b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HEALTH SURVEY; HUMAN; HYPERTENSION; PATIENT ATTITUDE; PATIENT EDUCATION; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; STROKE;

EID: 34247232620     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.4.518     Document Type: Article

References (21)

1. Katzan IL, Hammer MD, Hixson ED, et al. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol. 2004;61:346-350.
2. Burgin WS, Staub L, Chan W, et al. Acute stroke care in non-urban emergency departments. Neurology. 2001;57:2006-2012.
3. Ruland S, Gorelick PB, Schneck M, Kim D, Moore CG, Leurgans S. Acute stroke care in Illinois: a statewide assessment of diagnostic and treatment capabilities. Stroke. 2002;33:1334-1339.
4. Goldstein LB, Hey LA, Laney R. North Carolina stroke prevention and treatment facilities survey: statewide availability of programs and services. Stroke. 2000;31:66-70.
5. Haskins RJ, Kallail KJ. Staffing in small rural hospital emergency rooms: dependence on community family physicians. Fam Pract Res J. 1994;14:67-75.
6. Wang S, Gross H, Lee SB, et al. Remote evaluation of acute ischemic stroke in rural community hospitals in Georgia. Stroke. 2004;35:1763-1768.
7. Silliman SL, Quinn B, Huggett V, Merino JG. Use of a field-to-stroke center helicopter transport program to extend thrombolytic therapy to rural residents. Stroke. 2003;34:729-733.
8. Adams HP Jr, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke, a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation. 1996;94:1167-1174.
9. United States Bureau of the Census. Urban/Rural and Metropolitan/ Nonmetropolitan Population: 2000. http://factfinder.census.gov/servlet/GCTTable?
10. Alberts MJ, Hademenos G, Latchaw RE, et al. Recommendations for the establishment of primary stroke centers: Brain Attack Coalition. JAMA. 2000;283:3102-3109.
11. Silverman IE, Beland DK, Chhabra J, McCullough LD. The "drip-and-ship" approach: starting IV t-PA for acute ischemic stroke at outside hospitals prior to transfer to a regional stroke center. Conn Med. 2005;69:613-620.
12. Schneider AT, Pancioli AM, Khoury JC, et al. Trends in community knowledge of the warning signs and risk factors for stroke. JAMA. 2003;289:343-346.
13. Morgenstern LB, Staub L, Chan W, et al. Improving delivery of acute stroke therapy: the TLL Temple Foundation Stroke Project. Stroke. 2002;33:160-166.
14. Hlatky MA, Cotugno HE, Mark DB, O'Connor C, Califf RM, Pryor DB. Trends in physician management of uncomplicated acute myocardial infarction: 1970 to 1987. Am J Cardiol. 1988;61:515-518.
15. Chapman GD, Ohman EM, Topol EJ, et al. Minimizing the risk of inappropriately administering thrombolytic therapy (Thrombolysis and Angioplasty in Myocardial Infarction [TAMI] study group). Am J Cardiol. 1993;71:783-787.
16. Wang MY, Lavine SD, Soukiasian H, Tabrizi R, Levy ML, Giannotta SL. Treating stroke as a medical emergency: a survey of resident physicians' attitudes toward "brain attack" and carotid endarterectomy. Neurosurgery. 2001;48:1109-1115.
17. Merino JG, Silver B, Wong E, Demaerschalk B, Tamayo A, Hachinski V. Physician knowledge of the benefits, risks, and contraindications of tissue plasminogen activator for acute ischemic stroke. Stroke. 2001;32:2208-2209.
18. Gamm L, Hutchison L. Rural health priorities in America: where you stand depends on where you sit. J Rural Health. 2003;19:209-213.
19. Kleindorfer D, Hill MD, Woo D, et al. A description of Canadian and United States physician reimbursement for thrombolytic therapy administration in acute ischemic stroke. Stroke. 2005;36:682-687.
20. Katzan IL, Sila CA, Furlan AJ. Community use of intravenous tissue plasminogen activator for acute stroke: results of the brain matters stroke management survey. Stroke. 2001;32:861-865.
21. Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance: a systematic review of the effect of continuing medical education strategies. JAMA. 1995;274:700-705.